ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce the sponsorship of a Research Fellowship in Applied Pharmacology at the Swine Medicine Education Center of Iowa State University.

August 1, 2014 - ECO Animal Health together with Pharmgate Animal Health are delighted to announce the launch of the ECO/Pharmgate Animal Health Research Fellowship in Applied Pharmacology at the Swine Medicine Education Center of Iowa State University. This fellowship provides resources to graduate students to enable them to obtain a world-class education at Iowa State University's College of Veterinary Medicine.

Dr. Paisley Canning is the recipient of the first Fellowship and her thesis will investigate the epidemiology, pharmacology and disposition of macrolide antibiotics, particularly tylvalosin, in the joints and the respiratory system of healthy and mycoplasma infected swine.

Work previously reported by the SMEC lists Mycoplasma hyosynoviae and M hyorhinis as being of the more important pathogens in infectious lameness cases in pigs. The prevalence of these two organisms in adverse lameness, polyserositis and respiratory cases has been reported with increasing regularity at swine veterinary conferences 1.

Dr. Canning is already working on the research program and says, "This fellowship is aligned well with the service and research performed by the Swine Medicine Education Center and will generate valuable data to assist with the judicious use of tylvalosin in mycoplasma infected swine. I am grateful to have received this fellowship and I am eager to develop my understanding of the pharmacology of macrolides, particularly tylvalosin, through study and primary research."

Dr. Pat Halbur, Chair of the Veterinary Diagnostic and Production Animal Medicine Department where SMEC is located notes: "We very much appreciate ECO Animal Health's contribution to the Swine Medicine Education Center through the Research Fellowship in Applied Pharmacology. This model of industry-academic fellowships has proven to be a very productive and effective first step in establishing long term relationships between private industry and academia that evolve into research projects that benefit both parties and impact the industry and in the process provide educational and research experience for future leaders in academia and industry."

"We are very pleased to be contributing to the science of mycoplasma related disease control and supporting the SMEC in its research and educational objectives. This work will provide valuable explanation for recent field observations" says Dr. Ron Kaptur, Technical Service Veterinarian for Pharmgate Animal Health, who will serve as the company's liaison with the SMEC for this project.

ECO Animal Health, London U.K., is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets including Aivlosin®, as well as a range of branded generic animal health therapeutic products.

About Pharmgate LLC
Pharmgate LLC is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., P. R. China, the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride, salinomycin and other animal health compounds. The company has marketing or supply approvals for these products in most major markets throughout the world.

BLUE BIRD LABELS

View Labels »

GLOBAL VET LINK

Visit Website »

NEWS

  • October 12, 2016 Pharmgate concludes merger with ProtaTek International, Inc.

    September 15, 2016 Pharmgate announces agreement to acquire ProtaTek International, Inc.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

    August 1, 2016 - Pharmgate announces new appointments.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

  • November 25, 2013 - Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.

    August 13, 2015 - Pharmgate is pleased to announce the relocation of its headquarters from Ramsey, New Jersey to Wilmington, North Carolina.

  • March 17, 2014 - Pharmgate Animal Health announces the Canadian launch of Aivlosin® 17% Tylvalosin Medicated Premix for the treatment of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine

    August 8, 2013 - Pharmgate acquires chlortetracycline product licenses in Latin America.

  • August 1, 2014 - ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce...

    August 1, 2014 - Pharmgate Animal Health announces two Sales and Marketing appointments.

  • November 3, 2014 - Pharmgate concludes acquisition of Pennfield Animal Health

    October 16, 2014 - Pharmgate announces agreement to acquire the assets of Pennfield Animal Health.

CONTACT US

Pharmgate Animal Health LLC
1015 Ashes Drive, Suite 102
Wilmington, NC 28405
Tel: 1-800-380-6099
Fax: 910-679-8368

Pharmgate Animal Health Canada, Inc.
5204 Tenth Line, R.R. #2
Erin, Ontario N0B 1T0
Tel: 1-800-465-2450
Fax: 910-679-8368